Free Trial

Allurion Technologies Q3 2023 Earnings Report

Allurion Technologies logo
$2.94 +0.01 (+0.17%)
As of 03:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Allurion Technologies EPS Results

Actual EPS
-$15.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Allurion Technologies Revenue Results

Actual Revenue
$18.20 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Allurion Technologies Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Allurion Technologies Earnings Headlines

Allurion gets ‘Notification of Issuance’ from USPTO for obesity treatment
Free Stock Ticker Inside: This Indicator Caught Nvidia’s Rallies
I’m not one to make super bold statements… But today, I’m making an exception. Because I’m 100% convinced this is the best indicator I’ve used for trading Nvidia… Don’t believe me? Just take a look at the last two rallies: This powerful indicator caught both moves almost perfectly.
See More Allurion Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Allurion Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allurion Technologies and other key companies, straight to your email.

About Allurion Technologies

Allurion Technologies (NYSE:ALUR) focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

View Allurion Technologies Profile

More Earnings Resources from MarketBeat